The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital
Patients in pediatric oncological hospitals are at risk of developing a Clostridium difficile infection. The purpose of this study was to determine the risk of developing a Clostridium difficile infection in patients who are treated with antibiotics of different classes and their combinations by...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Doctrine
2020-11-01
|
| Series: | Microbiology Independent Research Journal |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.18527/2500-2236-2020-7-1-54-58 |
| _version_ | 1797221100047826944 |
|---|---|
| author | Mariya G. Shvydkaya Aleksandr M. Zatevalov Dzhamilya T. Dzhandarova Sergey D. Mitrokhin |
| author_facet | Mariya G. Shvydkaya Aleksandr M. Zatevalov Dzhamilya T. Dzhandarova Sergey D. Mitrokhin |
| author_sort | Mariya G. Shvydkaya |
| collection | DOAJ |
| description | Patients in pediatric oncological hospitals are at risk of developing a Clostridium difficile infection. The purpose of this study was to determine the risk of developing a Clostridium difficile infection in patients who are treated with antibiotics of different classes and their combinations by way of a retrospective analysis of 122 patient records. It was shown that the administration of antibacterial chemotherapeutic drugs that belong to the classes of nitrofurans (enterofuryl), sulfonamides (biseptol), cephalosporins, and macrolides/azalides significantly increased the risk of developing a Clostridium difficile infection in pediatric patients. On the contrary, treatment with antibiotics of different classes, such as linezolid, colistin, and metronidazole, significantly reduced the risk of developing a Clostridium difficile infection. The use of penicillins, aminoglycosides, fluoroquinolones, glycopeptides, and carbapenems was not associated with the risk of developing a Clostridium difficile infection in pediatric patients. The administration of one or two antimicrobial drugs of different classes increased the risk of developing a Clostridium difficile infection while a combination of three different types of antimicrobial drugs lowered the rate of this infection in pediatric patients. |
| first_indexed | 2024-03-11T07:15:51Z |
| format | Article |
| id | doaj.art-c0f744e69a2d4622ae72a2e1b71b5100 |
| institution | Directory Open Access Journal |
| issn | 2500-2236 |
| language | English |
| last_indexed | 2024-04-24T13:00:04Z |
| publishDate | 2020-11-01 |
| publisher | Doctrine |
| record_format | Article |
| series | Microbiology Independent Research Journal |
| spelling | doaj.art-c0f744e69a2d4622ae72a2e1b71b51002024-04-05T16:00:12ZengDoctrineMicrobiology Independent Research Journal2500-22362020-11-0171545810.18527/2500-2236-2020-7-1-54-58The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospitalMariya G. ShvydkayaAleksandr M. ZatevalovDzhamilya T. DzhandarovaSergey D. MitrokhinPatients in pediatric oncological hospitals are at risk of developing a Clostridium difficile infection. The purpose of this study was to determine the risk of developing a Clostridium difficile infection in patients who are treated with antibiotics of different classes and their combinations by way of a retrospective analysis of 122 patient records. It was shown that the administration of antibacterial chemotherapeutic drugs that belong to the classes of nitrofurans (enterofuryl), sulfonamides (biseptol), cephalosporins, and macrolides/azalides significantly increased the risk of developing a Clostridium difficile infection in pediatric patients. On the contrary, treatment with antibiotics of different classes, such as linezolid, colistin, and metronidazole, significantly reduced the risk of developing a Clostridium difficile infection. The use of penicillins, aminoglycosides, fluoroquinolones, glycopeptides, and carbapenems was not associated with the risk of developing a Clostridium difficile infection in pediatric patients. The administration of one or two antimicrobial drugs of different classes increased the risk of developing a Clostridium difficile infection while a combination of three different types of antimicrobial drugs lowered the rate of this infection in pediatric patients.https://www.scienceopen.com/hosted-document?doi=10.18527/2500-2236-2020-7-1-54-58 |
| spellingShingle | Mariya G. Shvydkaya Aleksandr M. Zatevalov Dzhamilya T. Dzhandarova Sergey D. Mitrokhin The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital Microbiology Independent Research Journal |
| title | The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| title_full | The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| title_fullStr | The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| title_full_unstemmed | The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| title_short | The risk of developing a Clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| title_sort | risk of developing a clostridium difficile infection from the administration of different classes of antibiotics and their combinations to children in an oncological hospital |
| url | https://www.scienceopen.com/hosted-document?doi=10.18527/2500-2236-2020-7-1-54-58 |
| work_keys_str_mv | AT mariyagshvydkaya theriskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT aleksandrmzatevalov theriskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT dzhamilyatdzhandarova theriskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT sergeydmitrokhin theriskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT mariyagshvydkaya riskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT aleksandrmzatevalov riskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT dzhamilyatdzhandarova riskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital AT sergeydmitrokhin riskofdevelopingaclostridiumdifficileinfectionfromtheadministrationofdifferentclassesofantibioticsandtheircombinationstochildreninanoncologicalhospital |